Alister Jack

Alister Jack

Ask VT AI
View News Summary
  • FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
  • Profitable companies with consistent earnings growth outperform speculative 'story stocks' without profits, as highlighted by the strong EPS growth of firms like Maxim Global, Nippon Life, and Cholamandalam.
  • Jaguars-Raiders Week 9 clash could shape trade deadline moves, with key injuries and player performances in focus.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
  • Profitable companies with consistent earnings growth outperform speculative 'story stocks' without profits, as highlighted by the strong EPS growth of firms like Maxim Global, Nippon Life, and Cholamandalam.
  • Jaguars-Raiders Week 9 clash could shape trade deadline moves, with key injuries and player performances in focus.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Alister Jack